Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

Cancer

Volumn 117, Issue 8, 2011, Pages 1775-1782

  Murphy, Rachel A ^a   Mourtzakis, Marina ^b   Chu, Quincy S C ^a   Baracos, Vickie E ^a   Reiman, Tony ^c   Mazurak, Vera C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

advanced cancer; body composition; cachexia; computed tomography imaging; n 3 fatty acids; weight loss

Indexed keywords

FISH OIL; ICOSAPENTAENOIC ACID; PLATINUM COMPLEX;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE MASS; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SKELETAL MUSCLE; WEIGHT REDUCTION;

BODY COMPOSITION; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; FISH OILS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NUTRITIONAL SUPPORT; STANDARD OF CARE;

EID: 79953800314     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25709     Document Type: Article

References (34)

1. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69: 491-497. (Pubitemid 10018703)
2. Read JA, Beale PJ, Volker DH, Smith N, Childs A, Clarke SJ., Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007; 15: 301-307. (Pubitemid 46295216)
3. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC., The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999; 81: 80-86. (Pubitemid 29415495)
4. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F., Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998; 82: 395-402. (Pubitemid 28060258)
5. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003; 52: 1479-1486. (Pubitemid 37176729)
6. Fearon KC, Barber MD, Moses AG, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006; 24: 3401-3407. (Pubitemid 46638896)
7. Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004; 22: 2469-2476. (Pubitemid 41115406)
8. Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003; 21: 129-134.
9. Bauer JD, Capra S., Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study. Support Care Cancer. 2005; 13: 270-274. (Pubitemid 40576515)
10. Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE., A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr. 2009; 89: 1173-1179.
11. Ross R., Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetol. 2003; 40 (suppl 1): S45-S50. (Pubitemid 37322716)
12. Murphy RA, Wilke MS, Perrine M, et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr. 2010; 29: 482-487.
13. Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol. 2001; 90: 2157-2165. (Pubitemid 32467407)
14. Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc. 2002; 50: 897-904. (Pubitemid 34496688)
15. Bauer J, Capra S, Ferguson M., Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002; 56: 779-785.
16. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC., Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000; 36: 177-184. (Pubitemid 30437038)
17. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007; 97: 823-831. (Pubitemid 46554396)
18. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
19. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization; 2000.
20. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE., A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008; 33: 997-1006.
21. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004; 97: 2333-2338. (Pubitemid 39552474)
22. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R., Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol. 2000; 89: 104-110. (Pubitemid 30482569)
23. Snyder WS, Cooke MJ, Mansett ES, Larhansen LT, Howells GP, Tipton IH., Report of the Task Group on Reference Man. Oxford, UK: Pergamon; 1975.
24. Pratt VC, Tredget EE, Clandinin MT, Field CJ., Fatty acid content of plasma lipids and erythrocyte phospholipids are altered following burn injury. Lipids. 2001; 36: 675-682. (Pubitemid 32777012)
25. Pratt VC, Tredget EE, Clandinin MT, Field CJ., Alterations in lymphocyte function and relation to phospholipid composition after burn injury in humans. Crit Care Med. 2002; 30: 1753-1761. (Pubitemid 34879586)
26. Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S., Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res. 2010; 49: 76-86.
27. Murphy RA, Mourtzakis M, Chu QS, Reiman T, Mazurak VC., Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in nonsmall cell lung cancer patients. J Nutr. 2010; 140: 1602-1606.
28. Moses AW, Slater C, Preston T, Barber MD, Fearon KC., Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004; 90: 996-1002. (Pubitemid 38495818)
29. Vansteenkiste JF, Vandebroek JE, Nackaerts KL, et al. Clinical-benefit response in advanced nonsmall-cell lung cancer: a multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine. Ann Oncol. 2001; 12: 1221-1230. (Pubitemid 32994749)
30. Goodpaster BH, Thaete FL, Kelley DE., Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr. 2000; 71: 885-892. (Pubitemid 30176569)
31. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002; 51: 144-151. (Pubitemid 34517991)
32. Asp ML, Tian M, Wendel AA, Belury MA., Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010; 126: 756-763.
33. Teran-Garcia M, Adamson AW, Yu G, et al. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c. Biochem J. 2007; 402: 591-600. (Pubitemid 46423896)
34. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F., Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord. 1997; 21: 637-643. (Pubitemid 27334170)